Imavita’s preclinical quality management system (QMS)
Our preclinical quality management system (QMS) is designed to trace all data related to the preclinical studies we manage, whether for our clients or for internal development.
The QMS records every detail of a study so that the data stay accessible and transparent. This traceability supports the reliability of the results we deliver to our clients.
Clients receive detailed study reports, and the traceability allows them to see how each result was generated.
Thanks to our QMS, Imavita provides experimental models that are reliable and reproducible, so that clients can progress their research and development with well-documented data.
By prioritizing quality and reliability, Imavita supports its clients’ preclinical research and development programs.
Contact the team to discuss how our QMS applies to your study, or explore our in vivo models.
Frequently asked questions about Imavita’s preclinical quality management system
What does the QMS cover?
The QMS is designed to trace all data related to the preclinical studies Imavita manages, for clients and for internal development projects.
What do clients receive?
Clients receive detailed study reports, supported by the traceability of the underlying data.
Is this a GLP quality system?
The QMS described here is a traceability system for study data. Imavita’s in vivo models page lists drug tolerance and safety studies as non GLP.
